Skip to main content

Peer Review reports

From: Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Original Submission
3 Jan 2006 Submitted Original manuscript
9 Feb 2006 Author responded Author comments - Alessandro Passardi
13 Jan 2006 Reviewed Reviewer Report - PierFranco Conte
13 Jan 2006 Reviewed Reviewer Report - federico cappuzzo
Resubmission - Version 2
9 Feb 2006 Submitted Manuscript version 2
2 Mar 2006 Author responded Author comments - Alessandro Passardi
13 Feb 2006 Reviewed Reviewer Report - federico cappuzzo
Resubmission - Version 3
2 Mar 2006 Submitted Manuscript version 3
7 Mar 2006 Author responded Author comments - Alessandro Passardi
Resubmission - Version 4
7 Mar 2006 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
13 Mar 2006 Author responded Author comments - Alessandro Passardi
Resubmission - Version 6
13 Mar 2006 Submitted Manuscript version 6
Publishing
21 Mar 2006 Editorially accepted
21 Mar 2006 Article published 10.1186/1471-2407-6-76

You can find further information about peer review here.

Back to article page